Alaina Ammit
Professor
Medicine
University of Sydney
Australia
Biography
Professor Alaina J. Ammit has earned an international reputation for her work elucidating the mechanistic basis of inflammation in asthma and airway remodelling. Her findings have important implications for identifying novel targets for drug therapy that will underpin new therapeutic opportunities to treat and prevent respiratory disease, which is a National Health Priority Area. Professor Ammit has received more than $6 million in peer-reviewed research funding (more than $3 million from NH&MRC), and published a career total of 96 articles in high-impact journals, including 17 invited reviews and a further six book chapters. To date, her publications have been cited over 3,000 times and her H-index is 30.
Research Interest
Asthma • COPD • Airway inflammation • Airway remodelling • Post-transcriptional regulation of gene expression • Endogenous phosphatases • Cellular signalling
Publications
-
Chai, A., Ammit, A., Gelissen, I. (2017). Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation. Respiratory Research, 18(1), 1-9
-
Patel, B., Kugel, M., Baehring, G., Ammit, A. (2017). Doxofylline does not increase formoterol-induced cAMP nor MKP-1 expression in ASM cells resulting in lack of anti-inflammatory effect. Pulmonary Pharmacology & Therapeutics, 45, 34-39
-
Prakash, Y., Halayko, A., Gosens, R., Panettieri, R., Camoretti-Mercado, B., Penn, R., Ammit, A. (2017). An official American thoracic society research statement: Current challenges facing research and therapeutic advances in airway remodeling. American Journal of Respiratory and Critical Care Medicine, 195(2), e4-e19.
